Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)
China · Delayed Price · Currency is CNY 6.25
-0.28 (-4.29%)
At close: Jul 30, 2026
SHA:688189 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,701 | 2,172 | 1,784 | 2,588 | 3,383 | 4,931 | |
Market Cap Growth | -47.62% | 21.75% | -31.04% | -23.51% | -31.39% | -27.96% |
Enterprise Value | 1,360 | 1,827 | 1,435 | 2,370 | 3,402 | 4,800 |
Last Close Price | 6.25 | 7.97 | 6.54 | 9.43 | 12.33 | 17.97 |
Forward PE | - | 15.16 | 15.16 | 15.16 | 15.16 | 15.16 |
PS Ratio | 13.35 | 15.31 | 7.09 | 3.59 | 4.84 | 6.63 |
PB Ratio | 2.45 | 3.05 | 2.03 | 2.01 | 2.61 | 3.54 |
P/TBV Ratio | 2.50 | 3.13 | 2.25 | 2.22 | 2.90 | 4.04 |
P/FCF Ratio | - | 62.48 | - | 14.08 | - | - |
P/OCF Ratio | 506.86 | 18.96 | 1280.46 | 12.02 | - | - |
EV/Sales Ratio | 10.68 | 12.88 | 5.70 | 3.29 | 4.87 | 6.46 |
EV/EBITDA Ratio | - | - | - | 58.91 | - | - |
EV/EBIT Ratio | - | - | - | 546.78 | - | - |
EV/FCF Ratio | - | 52.55 | - | 12.90 | - | - |
Debt / Equity Ratio | 0.01 | 0.01 | 0.25 | 0.25 | 0.42 | 0.34 |
Debt / EBITDA Ratio | - | - | - | 7.81 | - | - |
Debt / FCF Ratio | - | 0.29 | - | 1.77 | - | - |
Net Debt / Equity Ratio | -0.39 | -0.41 | -0.31 | -0.26 | -0.13 | -0.18 |
Net Debt / EBITDA Ratio | 3.55 | 4.40 | 0.87 | -8.48 | 5.16 | 1.43 |
Net Debt / FCF Ratio | 5.85 | -8.38 | 4.75 | -1.86 | 0.84 | 1.45 |
Asset Turnover | 0.13 | 0.14 | 0.17 | 0.39 | 0.34 | 0.35 |
Inventory Turnover | 2.17 | 2.16 | 2.83 | 4.24 | 2.67 | 1.94 |
Quick Ratio | 3.53 | 3.77 | 2.05 | 2.88 | 2.25 | 2.27 |
Current Ratio | 4.23 | 4.28 | 2.29 | 2.97 | 2.31 | 2.39 |
Return on Equity (ROE) | -20.00% | -18.83% | -35.61% | -0.84% | -7.26% | -12.09% |
Return on Assets (ROA) | -6.86% | -6.21% | -14.79% | 0.15% | -2.44% | -6.38% |
Return on Invested Capital (ROIC) | -25.87% | -19.65% | -44.86% | 0.42% | -7.03% | -20.19% |
Return on Capital Employed (ROCE) | -15.70% | -14.10% | -39.40% | 0.30% | -6.10% | -14.80% |
Earnings Yield | -8.36% | -6.30% | -19.42% | -0.42% | -2.33% | -3.28% |
FCF Yield | -2.70% | 1.60% | -3.20% | 7.10% | -5.94% | -3.58% |
Buyback Yield / Dilution | -0.06% | -0.00% | 0.02% | -0.03% | 0.01% | -6.66% |
Total Shareholder Return | -0.06% | -0.00% | 0.02% | -0.03% | 0.01% | -6.66% |